(Q28137628)

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The role of CCK caerulein, and CCK antagonists in nociception

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The probable arrangement of the helices in G protein-coupled receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Involvement of endogenous enkephalins in the mouse 'behavioral despair' test

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Opioid Control of the In Vitro Release of Cholecystokinin‐Like Material from the Rat Substantia Nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Inositol phosphates and cell signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Second-generation benzodiazepine CCK-B antagonists. Development of subnanomolar analogs with selectivity and water solubility

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Electrophysiological studies with new CCK analogs: correlation with binding affinity on B-type receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Two faces of cholecystokinin: anxiety and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Site of Attachment of Retinal in Rhodopsin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Neural basis of psychomotor stimulant and opiate reward: evidence suggesting the involvement of a common dopaminergic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cyclic cholecystokinin analogues with high selectivity for central receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Enzyme-resistant CCK analogs with high affinities for central receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Release of intracellular Ca2+ and elevation of inositol trisphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Gastrin-histamine interactions: direct and paracrine elements.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin-dopamine interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Biological actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

CCK in anxiety and cognitive processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The selective CCK-B agonist, BC 264 injected in the antero-lateral part of the nucleus accumbens, reduces the spontaneous alternation behaviour of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A two-trial memory task with automated recording: study in young and aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Heterogeneity of CCK-B receptors involved in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin antagonists--a toxicologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

On the distribution of cholecystokinin receptor binding sites in the human brain: an autoradiographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Investigation on the metabolism of CCK8 analogues by rat brain slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

[3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The origin of cholecystokinin terminals in the basal forebrain of the rat: evidence from immunofluorescence and retrograde tracing

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Amide bond replacements incorporated into CCK-B selective "dipeptoids"

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A selective role for dopamine in the nucleus accumbens of the rat in random foraging but not delayed spatial win-shift-based foraging.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Conformational analysis of cholecystokinin CCK26-33 and related fragments by 1H NMR spectroscopy, fluorescence-transfer measurements, and calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

"Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Analysis of variation in L-365,260 competition curves in radioligand binding assays

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Morphology of synapses formed by cholecystokinin-immunoreactive axon terminals in regio superior of rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The CCKB receptor antagonist, L-365,260, elicits antidepressant-type effects in the forced-swim test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Antidepressant-like effects of CCK(B) receptor antagonists: involvement of the opioid system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Conformationally restricted analogues of the potent CCK-B antagonist CI-988

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Species differences in the localization of 'peripheral' type cholecystokinin receptors in rodent brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

PD 135158, a CCKB/gastrin receptor antagonist, stimulates rat pancreatic enzyme secretion as a CCKA receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Differential Gene Expression of CCK(A) and CCK(B) Receptors in the Rat Brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Ac-[3- and 4-Alkylthioproline31]-CCK4 Analogs: Synthesis and Implications for the CCK-B Receptor-Bound Conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Expression cloning and characterization of the canine parietal cell gastrin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

New virginiamycin M1 derivatives: synthesis, cholecystokinin binding inhibitory and antimicrobial properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR 4-2J.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell Populations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Distribution of CCK mRNA in particular regions (hippocampus, periaqueductal grey and thalamus) of the rat by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Differential regulation of cholecystokinin- and muscarinic-receptor-mediated phosphoinositide turnover in Flow 9000 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Common or distinct receptors for gastrin and cholecystokinin in gastric mucosa?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

On the distribution of cholecystokinin B receptors in monkey brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Isomers of inositol trisphosphate in exocrine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A truncated isoform of human CCK-B/gastrin receptor generated by alternative usage of a novel exon

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Multiple D2 dopamine receptors produced by alternative RNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal afferent neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Quantitative autoradiographic localization of cholecystokinin receptors in rat and guinea pig brain using 125I-Bolton-Hunter-CCK8.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. II. Isolation, characterization and biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5–17) different in stimulating acid secretion in isolated rabbit gastric glands?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Endogenous opiates: 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Autoradiography of CCK receptors in the rat brain using [(3)H]Boc[Nle(28)(31)]CCK(27)-(33) and [(125)I]bolton-hunter CCK(8). Functional significance of subregional distributions.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The enhancement of morphine antinociception by a CCKB receptor antagonist in the rat depends on the phase of inflammation and the intensity of carrageenin-induced hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Regional distribution of calcitonin gene-related peptide-, substance P-, cholecystokinin-, Met5-enkephalin-, and dynorphin A (1-8)-like materials in the spinal cord and dorsal root ganglia of adult rats: effects of dorsal rhizotomy and neonatal caps

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin (CCK)-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Sequence alignment of the G-protein coupled receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Morphine action on cholecystokinin octapeptide release from rat periaqueductal grey slices: sensitisation by naloxone.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Distribution of neuropeptides in the limbic system of the rat: the amygdaloid complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Gastrin and CCK-8 induce inositol 1,4,5-trisphosphate formation in rabbit gastric parietal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Involvement of a pertussis toxin-sensitive G protein in the action of gastrin on gastric parietal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Biphasic kinetics of inositol 1,4,5-trisphosphate accumulation in gastrin-stimulated parietal cells. Effects of pertussis toxin and extracellular calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

In vivo release of CCK-8 from the dorsal horn of the rat: Inhibition by DAGOL

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Characterization and inhibition of a cholecystokinin-inactivating serine peptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Synthesis and biological activity of Boc [Nle28, Nle31]CCK27-33, a highly potent CCK8 analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Gastrin produces an immediate and dose-dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Is there a 'lock' for all agonist 'keys' in 7TM receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A comparative study on characterization and distribution of cholecystokinin binding sites among the rat, mouse and guinea pig brain

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Desensitization of cholecystokininB receptors in GH3 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Gastrin receptors on isolated canine parietal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Differential signal transduction by five splice variants of the PACAP receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin and morphine analgesia: variations on a theme

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The influence of guanyl nucleotide on agonist and antagonist affinity at guinea-pig CCK-B/gastrin receptors: binding studies using [3H]PD140376.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cognitive enhancing effects in young and old rats of pBC264, a selective CCK(B) receptor agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Direct demonstration of three different states of the pancreatic cholecystokinin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Implication of endogenous opioid system in the learned helplessness model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Second generation "peptoid" CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Differential involvement of phospholipase A2/arachidonic acid and phospholipase C/phosphoinositol pathways during cholecystokinin receptor activated Ca2+ oscillations in pancreatic acini

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Initial and sustained calcium mobilizations in the parietal cell during stimulations with gastrin, inositol trisphosphate, phorbol ester and exogenous diacylglycerol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

A site-directed mutagenesis study on the conserved alanine residue in the distal third intracellular loops of cholecystokininB and neurotensin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Novel CCK-B receptor agonists: diketopiperazine analogues derived for CCK4 bioactive conformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Regulation of central cholecystokinin recognition sites by guanyl nucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Brain CCK receptors: species differences in regional distribution and selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Animal models of depression: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Functional role of brain CCK receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Quinazolinone cholecystokinin-B receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021

Spatial localization in the Morris water maze in rats: acquisition is affected by intra-accumbens injections of the dopaminergic antagonist haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0082%2898%2900090-2

7 January 2021